Gh
Mostrando 25-36 de 1422 artigos, teses e dissertações.
-
25. Thyroid gland changes in patients with acromegaly
ABSTRACT Objective Acromegaly is characterized by high neoplastic morbidity as a side effect of growth hormone (GH) hypersecretion. Increased incidence of goiter, thyroid carcinoma, and thyroid dysfunction is also reported. The aim of the present study was to find the prevalence of thyroid dysfunction and goiter in patients with acromegaly and determine it
Arch. Endocrinol. Metab.. Publicado em: 2020-06
-
26. A Hidroterapia Reduz a Rigidez Arterial em Gestantes Hipertensas Crônicas
Resumo Fundamento A hipertensão arterial crônica (HAC) e o aumento da rigidez arterial (RA) elevam o risco de complicações na gestação, como pré-eclâmpsia sobreposta e baixo crescimento fetal. Objetivo Avaliar o impacto da hidroterapia, uma modalidade de tratamento não farmacológico, sobre a RA de gestantes com HAC. Métodos Estudo transversa
Arq. Bras. Cardiol.. Publicado em: 2020-04
-
27. [Exercício em plataforma vibratória aumenta a perfusão sanguínea da articulação do joelho e a temperatura retal de cães saudáveis]
RESUMO Foram avaliados os efeitos de dois protocolos de exercício em plataforma vibratória (PV) sobre as temperaturas dos joelhos e retais. Onze animais participaram de dois protocolos de exercício, diferentes na duração de cada exercício. O protocolo de exercício 1 (PE1) foi de 30 segundos e o PE2 foi de 60 segundos, com diferentes níveis vibratóri
Arq. Bras. Med. Vet. Zootec.. Publicado em: 2020-04
-
28. Is biochemical hypoglycemia necessary during an insulin tolerance test?
ABSTRACT Objective The insulin tolerance test (ITT) has been accepted as the gold standard test for assessing the integrity of the growth hormone (GH) – insulin-like growth factor (IGF-1) axis and the hypothalamic-pituitary-adrenal (HPA) axis. The goal of the test is to achieve clinical and biochemical hypoglycemia at a blood glucose level ≤ 40 mg/dL t
Arch. Endocrinol. Metab.. Publicado em: 2020-02
-
29. Growth Hormone insensitivity (Laron syndrome): Report of a new family and review of Brazilian patients
Abstract Laron’s syndrome (LS) is a rare genetic disorder characterized by insensitivity to growth hormone (GH). Up to the present time, over 70 mutations of GH receptor (GHR) gene have been identified leading to GH/insulin-like growth factor type 1 (IGF1) signaling pathway defect. The number of LS patients worldwide is unknown, as many are probably undiag
Genet. Mol. Biol.. Publicado em: 20/01/2020
-
30. Effects of growth hormone in the central nervous system
ABSTRACT Growth hormone (GH) is best known for its effect stimulating tissue and somatic growth through the regulation of cell division, regeneration and proliferation. However, GH-responsive neurons are spread over the entire central nervous system, suggesting that they have important roles in the brain. The objective of the present review is to summarize a
Arch. Endocrinol. Metab.. Publicado em: 10/01/2020
-
31. Laboratory investigations in the diagnosis and follow-up of GH-related disorders
ABSTRACT In addition to auxiological, clinical and metabolic features measurements of growth hormone (GH) and insulin-like growth factor I (IGF-I) complement our tools in diagnosis and follow-up of GH-related disorders. While comparably robust during the pre-analytical phase, measurement and interpretation of concentrations of both hormones can be challengin
Arch. Endocrinol. Metab.. Publicado em: 10/01/2020
-
32. The promise of growth hormone in sport: doped or duped
ABSTRACT Skeletal muscle is a target tissue of GH. Based on its anabolic properties, it is widely accepted that GH enhances muscle performance in sports. Athletic performance depends on muscle strength and the energy required to power muscle function. The energy required to power muscle function is derived from a continuum of anaerobic and aerobic sources. M
Arch. Endocrinol. Metab.. Publicado em: 10/01/2020
-
33. Update on new GH-IGF axis genetic defects
ABSTRACT The somatotropic axis is the main hormonal regulator of growth. Growth hormone (GH), also known as somatotropin, and insulin-like growth factor 1 (IGF-1) are the key components of the somatotropic axis. This axis has been studied for a long time and the knowledge of how some molecules could promote or impair hormones production and action has been g
Arch. Endocrinol. Metab.. Publicado em: 10/01/2020
-
34. Insulin signaling in the whole spectrum of GH deficiency
ABSTRACT GH is one of the insulin counterregulatory hormones which acts in the opposite way to insulin, increasing the glucose production by the liver and kidneys and decreasing glucose uptake from peripheral tissues, thus being a hyperglycemic hormone. When in excess, as in acromegaly, it induces glucose intolerance and diabetes. As expected, patients with
Arch. Endocrinol. Metab.. Publicado em: 10/01/2020
-
35. Personalized approach to growth hormone replacement in adults
ABSTRACT Growth hormone (GH) deficiency (GHD) in adults is well-characterized and includes abnormal body composition, reduced bone mass, an adverse cardiovascular risk profile, and impaired quality of life. In the early 1990s, it was also shown that patients with hypopituitarism without GH replacement therapy (GHRT) had excess mortality. Today, GHRT has been
Arch. Endocrinol. Metab.. Publicado em: 10/01/2020
-
36. New insights of growth hormone (GH) actions from tissue-specific GH receptor knockouts in mice
ABSTRACT In order to provide new insights into the various activities of GH in specific tissues, recent advances have allowed for the generation of tissue-specific GHR knockout mice. To date, 21 distinct tissue-specific mouse lines have been created and reported in 28 publications. Targeted tissues include liver, muscle, fat, brain, bone, heart, intestine, m
Arch. Endocrinol. Metab.. Publicado em: 10/01/2020